EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 210 filers reported holding EMERGENT BIOSOLUTIONS INC in Q4 2016. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,798,000 | +30.3% | 85,199 | +25.1% | 0.00% | 0.0% |
| Q3 2016 | $2,147,000 | +18.8% | 68,092 | +6.0% | 0.00% | 0.0% |
| Q2 2016 | $1,808,000 | -10.5% | 64,268 | +15.8% | 0.00% | 0.0% |
| Q1 2016 | $2,019,000 | +9.0% | 55,511 | +19.9% | 0.00% | 0.0% |
| Q4 2015 | $1,853,000 | +98.0% | 46,298 | +41.0% | 0.00% | 0.0% |
| Q3 2015 | $936,000 | -23.6% | 32,834 | -11.7% | 0.00% | 0.0% |
| Q2 2015 | $1,225,000 | -0.4% | 37,189 | -13.0% | 0.00% | 0.0% |
| Q1 2015 | $1,230,000 | +111.7% | 42,745 | +100.2% | 0.00% | – |
| Q4 2014 | $581,000 | -20.8% | 21,355 | -38.0% | 0.00% | – |
| Q3 2014 | $734,000 | -38.1% | 34,454 | -34.7% | 0.00% | -100.0% |
| Q2 2014 | $1,185,000 | -6.2% | 52,750 | +5.6% | 0.00% | 0.0% |
| Q1 2014 | $1,263,000 | +4.2% | 49,949 | -5.3% | 0.00% | 0.0% |
| Q4 2013 | $1,212,000 | +31.2% | 52,718 | +8.6% | 0.00% | 0.0% |
| Q3 2013 | $924,000 | +54.0% | 48,555 | +16.6% | 0.00% | – |
| Q2 2013 | $600,000 | – | 41,656 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Laurus Investment Counsel Inc. | 120,504 | $10,797,000 | 4.20% |
| SNYDER CAPITAL MANAGEMENT L P | 723,477 | $64,824,000 | 2.12% |
| Hillcrest Asset Management LLC | 161,428 | $14,464,000 | 1.97% |
| RICE HALL JAMES & ASSOCIATES, LLC | 587,727 | $52,660,000 | 1.85% |
| PALISADE CAPITAL MANAGEMENT, LP | 579,009 | $51,879,000 | 1.33% |
| Pier Capital, LLC | 109,786 | $9,837,000 | 1.04% |
| Paradiem, LLC | 21,320 | $2,286,000 | 0.97% |
| EARNEST PARTNERS LLC | 1,390,735 | $124,610,000 | 0.86% |
| Ridgewood Investments LLC | 10,004 | $1,034,000 | 0.82% |
| Tygh Capital Management, Inc. | 56,334 | $5,048,000 | 0.78% |